Stay updated on Comparing Weekly vs Twice-weekly Carfilzomib in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Comparing Weekly vs Twice-weekly Carfilzomib in Myeloma Clinical Trial page.

Latest updates to the Comparing Weekly vs Twice-weekly Carfilzomib in Myeloma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check23 days agoChange DetectedA banner announces an NIH website transition and says that “Super Intelligence” is replacing “Artificial Intelligence” in federal agency content.SummaryDifference0.6%

- Check30 days agoChange DetectedThe ClinicalTrials.gov page footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check37 days agoChange DetectedThe ClinicalTrials.gov site footer now displays revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check58 days agoChange DetectedThe study record history shows a new revision entry v3.7.0 added and the older revision v3.6.6 removed. This updates the version history to reflect the latest state of the record.SummaryDifference0.1%

- Check79 days agoChange DetectedA new Revision: v3.6.6 entry was added to the version history, and the previous Revision: v3.6.5 entry was removed.SummaryDifference0.1%

Stay in the know with updates to Comparing Weekly vs Twice-weekly Carfilzomib in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparing Weekly vs Twice-weekly Carfilzomib in Myeloma Clinical Trial page.